Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest expense |
146,000
EUR
|
339,000
EUR
|
| Adjustments for deferred tax expense |
86,000
EUR
|
449,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
5,408
EUR
|
3,337
EUR
|
| Adjustments for decrease (increase) in other assets |
-
EUR
|
743,000
EUR
|
| Adjustments for increase (decrease) in other liabilities |
6,000
EUR
|
1,273
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
194,000
EUR
|
106,000
EUR
|
| Adjustments for decrease (increase) in biological assets |
325,000
EUR
|
32,000
EUR
|